dostęp płatny
Zalecenia w zakresie profilaktyki półpaśca u biorców przeszczepów narządów litych w Polsce
- Klinika Nefrologii, Transplantologii i Chorób Wewnętrznych, Gdański Uniwersytet Medyczny
- Klinika Medycyny Transplantacyjnej, Nefrologii i Chorób Wewnętrznych, Warszawski Uniwersytet Medyczny
- Klinika Chorób Zakaźnych, Hepatologii i Transplantacji Wątroby, Pomorski Uniwersytet Medyczny w Szczecinie
- Klinika Chirurgii Serca, Klatki Piersiowej i Transplantologii, Pododdział Zaawansowanej Niewydolności Serca i Mechanicznego Wspomagania Krążenia, Centralny Szpital Kliniczny Uniwersyteckiego Centrum Klinicznego, Warszawski Uniwersytet Medyczny
- Klinika Chorób Zakaźnych i Hepatologii, Uniwersytet Medyczny w Białymstoku
- Klinika Kardiochirurgii, Transplantologii, Chirurgii Naczyniowej i Endowaskularnej, Śląski Uniwersytet Medyczny w Katowicach, Śląskie Centrum Chorób Serca w Zabrzu
dostęp płatny
Streszczenie
Herpes zoster (i.e. shingles) is a widespread infectious disease caused by reactivation of the varicellazoster virus. Although the cutaneous manifestation of the disease is the most common, shingles is also associated with numerous complications, e.g. neurological, including postherpetic neuralgia. It is estimated that one-third of the general population will develop herpes zoster during their lifetime, and the incidence in solid organ recipients is even higher. What is more transplant recipients are more likely to suffer from severe complications of the disease. The most effective method of preventing herpes zoster is vaccination. The only vaccine recommended and available in Poland is recombinant adjuvanted zoster vaccine. Its safety and effectiveness were demonstrated in both the general adult population and solid organ recipients. In this article, we present the position of experts in transplantation and infectious diseases on herpes zoster prevention in the solid organ transplant recipient population. The group includes kidney, liver, lung, and heart recipients.
Streszczenie
Herpes zoster (i.e. shingles) is a widespread infectious disease caused by reactivation of the varicellazoster virus. Although the cutaneous manifestation of the disease is the most common, shingles is also associated with numerous complications, e.g. neurological, including postherpetic neuralgia. It is estimated that one-third of the general population will develop herpes zoster during their lifetime, and the incidence in solid organ recipients is even higher. What is more transplant recipients are more likely to suffer from severe complications of the disease. The most effective method of preventing herpes zoster is vaccination. The only vaccine recommended and available in Poland is recombinant adjuvanted zoster vaccine. Its safety and effectiveness were demonstrated in both the general adult population and solid organ recipients. In this article, we present the position of experts in transplantation and infectious diseases on herpes zoster prevention in the solid organ transplant recipient population. The group includes kidney, liver, lung, and heart recipients.
Pełny tekst:
Dodaj do koszyka: 49,00 PLNSłowa kluczowe
herpes zoster prevention, solid organ transplant recipients, vaccination
Tytuł
Zalecenia w zakresie profilaktyki półpaśca u biorców przeszczepów narządów litych w Polsce
Czasopismo
Forum Nefrologiczne - Edukacja
Numer
Typ artykułu
Poglądy, stanowiska, zalecenia, standardy
Strony
146-154
Opublikowany online
2024-01-11
Wyświetlenia strony
135
Wyświetlenia/pobrania artykułu
28
Rekord bibliograficzny
Forum Nefrologiczne - Edukacja 2023;3(4):146-154.
Słowa kluczowe
herpes zoster prevention
solid organ transplant recipients
vaccination
Autorzy
Alicja Dębska-Ślizień
Magdalena Durlik
Marta Wawrzynowicz-Syczewska
Małgorzata Sobieszczańska-Małek
Robert Flisiak
Maciej Urlik